Close Menu

NEW YORK (GenomeWeb) ­– Abbott reported Wednesday morning that first quarter sales in its Diagnostics business grew 2 percent year over year, buoying flat overall revenue growth for the company.

For the three months ended March 31, Abbott reported overall Q1 revenues of $4.89 billion, down a fraction of a percent from Q1 last year, but up 5 percent year over year excluding unfavorable foreign currency effects. The company beat the consensus Wall Street estimate of $4.78 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.